Sofosbuvir and Ribavirin for 24 Weeks Is An Effective Treatment Option for Recurrent Hepatitis C Infection After Living Donor Liver Transplantation.

Anand, Anil C; Agarwal, Shaleen K; Garg, Hitendra K; Khanna, Sudeep; Gupta, Subhash.

Anand AC; Department of Hepatology & Gastroenterology, Indraprastha Apollo Hospital, Sarita Vihar, Mathura Road, New Delhi 110076, India.
Agarwal SK; Department of Hepatology & Gastroenterology, Indraprastha Apollo Hospital, Sarita Vihar, Mathura Road, New Delhi 110076, India.
Garg HK; Department of Hepatology & Gastroenterology, Indraprastha Apollo Hospital, Sarita Vihar, Mathura Road, New Delhi 110076, India.
Khanna S; Department of Hepatology & Gastroenterology, Indraprastha Apollo Hospital, Sarita Vihar, Mathura Road, New Delhi 110076, India.
Gupta S; Department of Hepatology & Gastroenterology, Indraprastha Apollo Hospital, Sarita Vihar, Mathura Road, New Delhi 110076, India.

J Clin Exp Hepatol ; 7(3): 165-171, 2017 Sep.

Article en En | MEDLINE | ID: mdl-28970701

Palabras clave

CBC, complete blood counts; DAA, directly acting antivirals; HCC, hepatocellular carcinoma; HCV, hepatitis C virus; Hb%, hemoglobin; KFT, kidney function tests; LDLT, living donor liver transplantation; LFT, liver function tests; LT, liver transplantation; RBV, ribavirin; SOF, sofosbuvir; SVR, sustained virological response; g/dL, grams per decilitre; genotype-1; genotype-3; kPA, kilo pascals; living donor liver transplantation; recurrent hepatitis C; sustained viral response

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2017 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Año: 2017 Tipo del documento: Article